Alexandria Venture Investment

Alexandria Venture Investment

Alexandria Venture Investment

Suggest edits
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 12

Portfolio

Portfolio Tracker

Add info
Avelas Biosciences

Avelas Biosciences

Biotechnology
Total funding
$34.5M in 3 rounds from 6 investors
By Alexandria Venture Investment
$20M Series C in Aug, 2016
Biological Dynamics, Inc.

Biological Dynamics, Inc.

Biotechnology
Total funding
$26.8M in 1 rounds from 4 investors
By Alexandria Venture Investment
$26.8M Series C in Nov, 2015
EpiBiome

EpiBiome

Biotechnology
Total funding
$7.1M in 3 rounds from 8 investors
By Alexandria Venture Investment
$6M Series A in Feb, 2016
Frequency Therapeutics

Frequency Therapeutics

Medical +2
Total funding
$106M in 3 rounds from 13 investors
By Alexandria Venture Investment
$42M Series B in Jan, 2019
Magnolia Neurosciences

Magnolia Neurosciences

Medical +2
Total funding
$62M in 2 rounds from 14 investors
By Alexandria Venture Investment
$31M Series A in Aug, 2018
Syros Pharmaceuticals

Syros Pharmaceuticals

Biotechnology
Total funding
$123M in 3 rounds from 11 investors
By Alexandria Venture Investment
$40M Series C in Jan, 2016
Verseau Therapeutics

Verseau Therapeutics

Clinical Trials +1
Total funding
$50M in 1 rounds from 7 investors
By Alexandria Venture Investment
$50M Undisclosed in Oct, 2019
Vtesse, Inc.

Vtesse, Inc.

Biotechnology
Total funding
$42M in 2 rounds from 5 investors
By Alexandria Venture Investment
$17M Series A in Jul, 2016

Want to see the complete list?
Go Pro!